A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Fumagalli, Ingrid ^a   Bibault, Jean Emmanuel ^a   Dewas, Sylvain ^a   Kramar, Andrew ^a   Mirabel, Xavier ^a   Prevost, Bernard ^a   Lacornerie, Thomas ^a   Jerraya, Hajer ^a   Lartigau, Eric ^a  

^a Oscar Lambret Comprehensive Cancer Center   (France)

Author keywords

CyberKnife; Liver metastasis; Lung metastasis; Oligometastases; SBRT

Indexed keywords

ADULT; AGED; ANOREXIA; ARTICLE; ASTHENIA; CANCER CHEMOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CYBERKNIFE; DISEASE FREE SURVIVAL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER PAIN; LOCAL RECURRENCE FREE SURVIVAL; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA EFFUSION; RADIATION INJURY; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84866722623     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-164     Document Type: Article

References (18)

1. Herfarth KK, Debus J, Lohr F, Bahner ML, Rhein B, Fritz P, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001, 19(1):164.
2. Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J RadiationOncology* Biology* Physics 2005, 62(5):1371-1378.
3. Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003, 124(5):1946-1955. 10.1378/chest.124.5.1946, 14605072.
4. Schefter TE, Kavanagh BD, Raben D, Kane M, Chen C, Stuhr K, et al. A phase I/II trial of stereotactic body radiation therapy (SBRT) for lung metastases: Initial report of dose escalation and early toxicity. Int J Radiat Oncol Biol Phys 2006, 66(4):S120-S127.
5. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995, 13(1):8-10.
6. Milano MT, Katz AW, Zhang H, Okunieff P. Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study. Int J RadiationOncology, Biology, Physics 2012, 83(3):878-886.
7. Macdermed DM, Weichselbaum RR, Salama JK. A rationale for the targeted treatment ofoligometastases with radiotherapy. J Surg Oncol 2008, 98(3):202-206. 10.1002/jso.21102, 18618604.
8. Okunieff P, Petersen AL, Philip A, Milano MT, Katz AW, Boros L, et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 2006, 45(7):808-817. 10.1080/02841860600908954, 16982544.
9. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial Radiosurgery (Stereotactic Body RadiationTherapy) for Oligometastases. Semin Radiat Oncol 2006, 16(2):77-84. avr, 10.1016/j.semradonc.2005.12.003, 16564443.
10. Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. International Journal ofRadiation Oncology* Biology* Physics 2007, 67(3):793-798.
11. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009, 27(10):1579. 10.1200/JCO.2008.19.6386, 19255320.
12. McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh B. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiation Oncology* Biology* Physics 2009, 73(1):112-118.
13. Salama JK, Hasselle MD, Chmura SJ, Malik R, Mehta N, Yenice KM, et al. Stereotactic bodyradiotherapy for multisite extracranial oligometastases: Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 2012, 118(11):2962-2970. 10.1002/cncr.26611, 22020702.
14. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004, 60(1):186-196. 10.1016/j.ijrobp.2004.02.060, 15337555.
15. Siva S, MacManus M, Ball D. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. J Thorac Oncol 2010, 5(7):1091.
16. Ricardi U, Filippi AR, Guarneri A, Ragona R, Mantovani C, Giglioli F, et al. Stereotactic body radiation therapy for lung metastases. Lung Cancer 2012, 75(1):77-81. 10.1016/j.lungcan.2011.04.021, 21726918.
17. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, et al. Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases. Journal ofClinical Oncology 2009, 27(10):1572-1578. avr 1.
18. Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009, 27(10):1585. 10.1200/JCO.2008.20.0600, 19255313.